Niagen Bioscience Announces External Research Milestone, Surpassing 300 Material Transfer Agreements In NAD+ Research

Niagen Bioscience has surpassed 300 Material Transfer Agreements in its NAD+ research program, which has generated over $200 million in third-party research value or funding. This milestone highlights the significant external investment from researchers and institutions in the study of Niagen and NAD+ biology.